3,409 results on '"Positron Emission Tomography"'
Search Results
2. 'Helically-Arranged Positron Emission Tomography Detector Units' in Patent Application Approval Process (USPTO 20240302550)
3. New Epstein-Barr Virus Study Findings Have Been Published by Researchers at Capital Medical University (Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using 18F-FDG PET/CT and nomogram integration)
4. PET scan: o que é o exame e quando ele é indicado
5. Jubilant Pharmova arm to expand PET radiopharmacy network in US; invests $50 Million.
6. Tau Blood Test Flags Preclinical Alzheimer's Disease.
7. Federal Grant Of $3 Million Allocated For Lung Infections Study Led By Indian American.
8. US FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
9. New blood test accurately detects Alzheimer's disease
10. Ana Maria Braga vence mais uma vez o cancer: 'Sumiu tudo'
11. Phillies' earliest scheduled opener in history will become known as the day when no one played
12. GE expands advanced imaging activities in Israel
13. Nawaz to be hospitalized for treatment
14. Dr Yasmin talks under pressure: Marriyum
15. An eye exam could detect early signs of Alzheimer's
16. After US withdrawal from Iran nuclear deal, restored sanctions put cancer patients at risk
17. Doctors advise shifting Nawaz to US for treatment
18. Enlarged lymph nodes detected in Nawaz's right axilla: Dr Adnan
19. A Surprising Beneficiary of New Alzheimer's Drugs: GE HealthCare.
20. New consensus on biomarkers for diagnosis of neurocognitive disorders.
21. APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development
22. The Supply, Delivery, Installation And Maintenance Of A Positron Emission Tomography Imaging System
23. UK Contract Notice: Medicines Discovery Catapult Issues Solicitation for 'The Supply, Delivery, Installation and Maintenance of a Positron Emission Tomography Imaging System'
24. Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent
25. FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer
26. FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
27. United States : FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
28. FDA APPROVES FIRST PSMA-TARGETED PET IMAGING DRUG FOR MEN WITH PROSTATE CANCER
29. Supply And Installation Of Digital Positron Emission Tomography And Computed Tomography (pet|Ct) System
30. Guideline For Testing Amyloid Positron Emission Tomography In Dementia Of Unclear Etiology
31. John Hunter Hospital - Design Finalisation And Construction - Pet Scanner Works
32. Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent in Collaboration with Nucleis Radiopharmaceuticals
33. Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent rhPSMA-7.3 (18F) in Collaboration with Nucleis Radiopharmaceuticals in Liege, Belgium
34. EU Contract Notice: JZU University institute of positron emission tomography Issues contract notice|solicitation for 'North Macedonia-Skopje: Medical equipments, pharmaceuticals and personal care products'
35. NSK linear motion systems provide 'clear' benefits for medical imaging systems
36. Scientists expand PET imaging options through simpler chemistry
37. Deliveries Of Radiopharmaceuticals Naf For Positron Emission Tomography Nnh
38. Deliveries Of Naf Radiopharmaceuticals For Nnh Positron Emission Tomography
39. Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL[TM] (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent
40. EMORY FIRST IN GEORGIA TO OFFER PATIENTS ACCESS TO NEW PET/CT SCANNER FOR IMPROVED DIAGNOSIS AND TREATMENT
41. Leading Physicians Highlight Groundbreaking Potential of Radiopharmaceuticals in Oncology and Need for Expanded Patient Access
42. Open Call For Tenders N 09 Ph 20 - Supply Of Radiopharmaceutical Medicinal Products Branded With Fluor 18 Used In Positron Emission Tomography The Consultation Consists Of 3 Lots
43. Deliveries Of Radiopharmaceuticals Naf, Flt And Fch For Positron Emission Tomography For Nnh
44. Positron Emission Tomography Devices Market Key Companies Profile, Research and Insights By 2023
45. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer
46. New research reveals in vivo trafficking of vitamins using positron emission tomography
47. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer
48. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer
49. Supply Of Radiopharmaceuticals For Positron Emission Tomography
50. Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.